Application of the decentralized & digitalized clinical trial model in cardiovascular clinical research
Author:
Affiliation:

1.Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University & National Clinical Research Center for Cardiovascular Diseases, Beijing 100029, China;2.Department of Cardiovascular Medicine, Changsha Hospital Affiliated to Xiangya Medical College (Changsha First Hospital), Central South University, Changsha, Hunan 410000, China)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    As a new clinical trial mode, decentralized & digitalized clinical trial (DCT) is based on digital health equipment and uses internet and artificial intelligence technologies to complete the screening, registration, randomization, intervention, evaluation and follow-up of subjects, which is helpful to improve efficiency and reduce trial costs. The DCT mode has been applied to evaluate the treatment and management effects of cardiovascular diseases such as atrial fibrillation, heart failure, coronary heart disease, and hypertension, showing broad development prospects and application space. This article will provide a brief introduction to representative DCT in the global cardiovascular disease field, and look forward to the application prospects of this model, providing reference and guidance for accelerating the development of cardiovascular DCT in China.

    Reference
    Related
    Cited by
Get Citation

YANG Zejun, ZHAO Manlin, PENG Xiaodong, ZHANG Jingrui, LI Sitong, YUAN Cong, HE Liu, MA Changsheng. Application of the decentralized & digitalized clinical trial model in cardiovascular clinical research[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2024,32(10):829-834.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:July 30,2024
  • Revised:September 24,2024
  • Online: October 22,2024
Article QR Code